Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUSP525L mutation

Hitoshi Aizawa, Takuto Hideyama, Takenari Yamashita, Takashi Kimura, Naoki Suzuki, Masashi Aoki, Shin Kwak

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Mutations in the fused in sarcoma (FUS) gene can cause amyotrophic lateral sclerosis (ALS), and FUS gene mutations have been reported in sporadic ALS patients with basophilic cytoplasmic inclusions. Deficiency of adenosine deaminase acting on RNA 2 (ADAR2), an enzyme that specifically catalyzes GluA2 Q/R site-editing, has been reported in considerable proportions of spinal motor neurons of the majority of sporadic ALS patients. We describe the relationship between GluA2 Q/R site-editing efficiency and FUS-positive inclusions in a patient with FUSP525L. A 24-year-old woman with ALS presented with basophilic cytoplasmic inclusions, significantly reduced GluA2 Q/R site-editing efficiency in the spinal motor neurons, and markedly decreased ADAR2 mRNA levels. Neuropathologic examination showed that not all spinal motor neurons expressed ADAR2 and revealed FUS-positive cytoplasmic inclusions in motor neurons irrespective of ADAR2 immunoreactivity. There were no phosphorylated transactive response (TAR) DNA-binding protein 43 kDa (TDP-43)-positive inclusions, indicating that there was no tight correlation between ADAR2 deficiency and TDP-43 deposition. ADAR2 deficiency can occur in ALS patients with a FUSP525L mutation and is unrelated to the presence of FUS-positive inclusions. FUS-associated ALS may share neurodegenerative characteristics with classical sporadic ALS.

Original languageEnglish
Pages (from-to)128-129
Number of pages2
JournalJournal of Clinical Neuroscience
Volume32
DOIs
Publication statusPublished - 2016 Oct 1

Keywords

  • Adenosine deaminase acting on RNA 2
  • Amyotrophic lateral sclerosis
  • Fused in sarcoma

ASJC Scopus subject areas

  • Surgery
  • Neurology
  • Clinical Neurology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Deficient RNA-editing enzyme ADAR2 in an amyotrophic lateral sclerosis patient with a FUS<sup>P525L</sup> mutation'. Together they form a unique fingerprint.

Cite this